About the journal: Wound Management & Prevention (formerly Ostomy Wound Management) is a peer-reviewed, multi- and interdisciplinary journal dedicated to informing the practice, advancing the science, and improving the evidence base of all aspects of wound, continence, ostomy, and skin care.
Wound Management & Prevention is indexed in MEDLINE© and the Cumulative Index to Nursing and Allied Health (CINAHL©) and included in the Thomson Reuters Scientific Database and the British Nursing Index. To further meet its editorial purpose and reduce potential barriers to accessing published information, single copies of all published articles (in PDF or HTML format or both) are available free of charge at the Wound Management & Prevention website (www.woundmanageprev.com); you are requested to register at the site without charge. There is no fee to publish in the journal, nor are there any fees associated with including figures/photographs.
All feature article submissions are peer reviewed. Because the Wound Management & Prevention Editorial Board recognizes the importance of a timely exchange of scientific information, authors usually receive a decision about their manuscript within 3 months of submission, and most submissions are published within 6 to 9 months following receipt of the final manuscript (see III).
Manuscripts that meet the Wound Management & Prevention editorial purpose include, but are not limited to:
1) Empirical studies/original data: Includes all direct and indirect observational studies (eg, pre-clinical and clinical studies, meta-analyses, surveys, and studies designed to evaluate changes in practice or educational intervention outcomes). This type of manuscript typically includes an introduction/literature review, methods, results, discussion, conclusion, references, tables/figures (optional but recommended). Section descriptions to follow;
2) Review articles: Critical evaluation of available information about a topic, including theories, using established literature review types and methods (includes introduction, methods, results, discussion, conclusion, references, tables/figures [optional but recommended]);
3) Methodological articles: Presents new methodological approaches, including modifications of existing methods or discussions about approaches to study designs or data analysis (includes introduction, methods, results, discussion, conclusion, references, tables/figures [optional but recommended]);
4) Case studies and descriptive articles: Detailed reports of observations from working with an individual, group, community, or organization that illustrate a problem and may help inform practice or future research (includes introduction/literature review, case/patient information, discussion, conclusion, references, tables/figures [optional but recommended]);
5) Brief reports: Brief reports are occasional publications of important observations that may affect patient care and outcomes, such as brief reviews of recent evidence; changes in health care policies, regulations, or reimbursement; and clinical study observations or unique clinical challenges (includes introduction, report data, summary, and 1 small table and/or 1 or 2 clinical pictures);
6) Opinions: Commentary on timely, important concerns relevant to the clinical, professional, regulatory, or legal arena in which readers practice. Article options include Guest Editorials, Special Report, and Can We Talk; and
7) Letters to the Editor: Responses to articles published in the journal. Letters are forwarded to the authors of the articles eliciting the commentary, and the original letter and the authors’ response are published.
All reports that involve human participants must describe Institutional Review Board (IRB) or Ethics committee approval procedures and how participants’ rights were protected and informed consent obtained.
Studies involving animals must describe procedures used to comply with all legal and ethical requirements of the institution(s) at which, and in the jurisdictions under which, the work was done. Manuscripts that do not contain this information will not be reviewed.
Statements and opinions (including specific drug dosages) expressed in Wound Management & Prevention are those of the authors and do not necessarily reflect those of the Editor, the Publisher, or any associated organizations (such as the Association for the Advancement of Wound Care). The Editor, Publisher, and the journal deny responsibility for such materials; they do not guarantee, warrant, or endorse any product or service advertised in this publication nor guarantee any claim made by the manufacturer of such product or service.
I. General Manuscript Preparation Guidelines
Wound Management & Prevention editorial policies for authors, reviewers, and editorial staff are based on the “Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication” published by the International Committee of Medical Journal Editors (ICMJE; for complete guidelines, visit: www.icmje.org). Guidelines for authors are based on the American Medical Association (AMA) Manual of Style, 10th edition (see: www.amamanualofstyle.com/oso/public/index.html). Authors of clinical studies, especially randomized controlled trials (RCTs), are expected to follow the minimum set of recommendations for reporting the results of their work promulgated by the CONSORT group (see: www.consort-statement.org/consort-statement/overview0/).
A few common concerns: All abbreviations must be spelled out when first used followed by the abbreviation in parentheses. Similarly, proprietary product name(s) and applicable copyright or trademark information should be included once in the body of the manuscript (not in the title or abstract), followed by the generic name in parentheses, which is then used throughout the remainder of the manuscript.
Before submitting the manuscript, authors are encouraged to contact the Editor by email or phone. In addition, prospective authors may want to discuss their ideas with the Clinical Editor or Editorial Board members.
II. Preparing the Manuscript
All manuscripts follow the same general format outlined below and are based on the AMA Manual of Style guidelines. The Editors of Wound Management & Prevention hesitate to put restrictions on word count. Manuscripts typically range from 2000 to 10 000 words, including references; the generally accepted manuscript length is 18 to 25 typewritten, double-spaced pages (not including tables and figures). Occasionally, references and tables/figures may be placed online only to conserve space in the print journal.
Criteria for authorship, as defined by the ICMJE and adopted by Wound Management & Prevention, include:
- substantial contributions to conception and design, data acquisition, analysis, or interpretation;
- drafting the article or revising it critically for important intellectual content; and
- final approval of the version to be published. Authors should meet conditions 1, 2, and 3.
All persons who meet the above criteria must be listed as authors. As part of the submission process, authors must indicate whether any writing assistance other than copy editing was provided.
Authors’ credentials, job title, and his/her facility name and location are published with the manuscript.
A.1. Student authors
Wound Management & Prevention encourages clinicians advancing their education to submit research and/or studies undertaken during or as part of their coursework. Novice authors may request an Editorial Board member mentor to critique and guide manuscript preparation by contacting the Editor. All manuscripts must conform with the journal’s style, tone, and level of scientific rigor; referencing and citations must follow AMA format (see II.J). Authors of published student manuscripts become eligible for a Student Author award, presented yearly, and free registration to one Symposium on Advanced Wound Care.
The title of the manuscript should convey the topic, clinical condition, or concern and content (eg, in vivo study, randomized controlled clinical study, literature review).
All manuscripts should be accompanied by a structured 150- to 200-word abstract containing:
- an introductory statement about the topic and/or concern;
- purpose of the paper or study;
- method(s) used;
- most salient findings, results, or observations; and
The abstract should be followed by 3 to 5 keywords. Authors should refer to the Medical Subject Headings (MeSH) vocabulary of the National Library of Medicine to find keywords pertaining to the type of manuscript (eg, study), health condition, and topic. These terms are available at: www.nlm.nih.gov/mesh/MBrowser.html.
D. Introduction and/or Literature Review
The purpose of an introduction and/or literature review for manuscripts is to describe the topic, summarize previous research and existing evidence, and identify relationships, contradictions, gaps, and inconsistencies. Summaries of previous research should use as many primary/original references and sources of information as possible. Secondary information sources (eg, review articles, textbooks) may be appropriate at times but should be identified as review articles, opinions, and the like. Throughout the manuscript, details about pertinent references used must be included to clarify the strength of existing evidence. Study type (eg, in vivo, case series), design (eg, retrospective), sample size, and summary of pertinent results must be included in the text.
E. Study/Publication Purpose
The study/publication purpose and design or hypothesis flows from and concludes the introduction.
F. Methods and Procedures
All methods and procedures must be described in detail, including literature search methods for literature reviews. IRB approval and informed consent procedures used must be included for all studies involving patient interventions or use/retrieval of clinical data (see also Ethical considerations). Authors of clinical studies, especially RCTs, should consult and follow the minimum set of recommendations for reporting the results of their work promulgated by the CONSORT group (see: www.consort-statement.org/consort-statement/overview0/). A description of data entry and analysis methods used usually concludes the methods and procedures.
F.1. Case studies/descriptive articles
Case studies should follow the same format as other types of clinical studies and include a detailed description of the patient(s) and address age, gender, clinical history (eg, comorbidities, medications, confounding factors), previous treatment(s), diagnosis, current treatments, outcomes, and prognosis.
All findings and results of all variables collected and analyzed are described in the text and, if appropriate, presented in tables and figures. Authors should follow AMA guidelines for the use of tables and figures. Figures are usually reserved for showing data patterns. Color photographs also can be helpful for illustrating observations.
Tables, figures, and illustrations should be numerically labeled in the order in which they are cited in the text (eg, “see Figure 1”) and should be labeled clearly. Titles and legends can be printed above, below, or next to the figure or table, or on a separate page following the conclusion. Titles and legends should provide enough detail to make illustrations comprehensible without reference to the text. Illustrations and tables should not be embedded within the text of the Word document submitted; they should appear at the end of the manuscript.
The discussion section evaluates and interprets the results and observations, especially with respect to the study or project hypothesis or purpose. The most salient findings are highlighted while similarities and differences between the results described and previously published studies and observations are examined. Limitations of the project or study (eg, small sample size, methodological limitations) are also described in, or just after, the discussion section. Suggestions for future research to answer new or remaining questions as well as potential implications for practice should be described.
The conclusion should recap the most salient parts of the research (purpose, type of study, key participants, key findings, conclusion, and implications for practice where relevant).
J. Acknowledgment (optional)
Additional contribution of human or financial resources are mentioned here.
References are numbered chronologically as they appear in the text. If a reference is cited multiple times, it is noted using the number of its initial appearance.
References are listed at the end of manuscript in the numerical order in which they appear in the text. All information needed to identify and retrieve the source must be included. Some examples:
- References to publications in journals, magazines, and other periodicals must include (please note appropriate punctuation): Author name(s) — last name and initials. Title of the article/work. Title of the periodical. Year;volume(issue number):page numbers.
- References to book chapters include: Author name(s). Title of the chapter. In: Editor(s) name(s) (ed[s]). Title of the book. Location of publisher: Publisher name;year: page numbers
- References to an online journal: Author name(s) — last name and initials. Title of the article/work. Title of the periodical. Year; volume(issue number):page numbers:doi.
- References to an online journal without a doi: Author name(s) — last name and initials. Title of the article/work. Title of the periodical. Year;volume(issue number):page numbers. Available at: website (http://site). Accessed month, day, year.
- References to an online article: Author name(s) – last name and initials. Title of the article/work. Journal/publication source (if available). Available at: website (http://site). Accessed month, day, year.
L. Tables and Figures
- Patient consent requirements according to privacy practices for dissemination of health information and for all patient photographs must be met. Patient releases must be available and provided when requested by the editors and/or as part of the manuscript submission process. See II.G.
III. Submitting the Manuscript
A. Cover Letter
The cover letter should indicate the manuscript title and the corresponding author and provide a complete address, daytime telephone number, fax number, and email address. If the manuscript contains a case study or research information, the corresponding author should explain in the cover letter how the rights and dignity of all participants involved were protected and where the information is included in the manuscript. Photographs will not be published without a signed statement of consent from the subject (or if the patient is a minor, from both parents or the legal guardian). Recently announced Standards for Commercial Support by the Accreditation Council for Continuing Medical Education, coupled with current market dynamics, have influenced the review/disclosure/publication process. Please note Wound Management & Prevention has and will continue to uphold these standards in its articles.
Authors will be required to complete financial disclosure forms and copyright transfer forms as part of the submission.
- Financial disclosure. Financial disclosures (ie, potential conflicts of interest) must be provided by all authors as part of the submission process.
- Studies involving animals. Authors submitting results of preclinical research should inform the editor about methods used to adhere to animal welfare regulations.
If a manuscript has been accepted with revisions, authors will be asked to return the revised manuscript within 3 to 4 weeks. If the authors cannot meet the specified deadline, an extension can be requested. Only requested revisions should be made. Revised manuscripts with changes not requested by the reviewers (eg, new data or information, changes in conclusion/interpretation of findings) will not be accepted and will be returned to the authors.
IV. Submission Criteria/Ethical and Legal Considerations
In accordance with AMA, American Psychological Association (APA), and ICMJE guidelines, duplicate or redundant publication of manuscripts is generally unacceptable. Failure to disclose the existence of duplicate articles, manuscripts, or other material is unethical and may represent a violation of copyright law. Exceptions to this rule, providing proper attribution to the report or disclosure of presentation is provided, may include summaries or abstracts of findings printed in conference proceedings, short reports of author findings distributed at meetings, reports from government documents or reports in the public domain, and translation of reports in another language. Material directly quoted from previously published work can be incorporated in a short quotation (with appropriate attribution). Approval from the copyright holder (institution, publisher, or author) to use more than 40 words or any tables, figures, and photographs from previously published work must be obtained in writing and provided to the Editors. Manuscripts submitted to Wound Management & Prevention are reviewed and accepted with the understanding that they have not been previously published and are not submitted for review elsewhere.
Upon submission of the manuscript, authors will be asked to confirm that the manuscript is original and does not contain substantial amounts of information or data that have been published elsewhere or have been submitted for review and publication elsewhere (journal/book/electronic publication medium). The author(s) also will be asked to accept copyright transfer, previous presentation/publication information, and to provide a financial support disclosure agreement. If the manuscript is not accepted for publication, the copyright transfer agreement will be returned to the author. Manuscripts accepted for publication are copyrighted in the volume and issue published. Materials reproduced without permission from HMP cannot exceed 50 words. Please note: Although HMP holds the copyright, no fee is assessed for the author to use/have access to the article for noncommercial/educational purposes.
Following publication of the manuscript, US-based authors (see “corresponding author” under Submission process) will receive 5 complimentary copies of the issue in which his/her article appears. All authors receive a PDF of the published article. Authors receive a discount when ordering reprints of their publications.
B. Errors and Misconduct
If an author identifies an error after the manuscript has been published, he/she must contact the Editor as soon as possible and prepare a letter correcting the error(s) for publication in the journal. The Editorial Policy Committee of the Council of Science Editors has identified the following general areas of research misconduct:
- unethical treatment of research subjects;
- fabrication of data;
- falsification of data; and
- plagiarism. Plagiarism includes the use of another person’s ideas, processes, results, or words without giving appropriate credit. When a manuscript has been accepted for publication, all authors will be asked to sign a statement related to data integrity, accuracy, and adherence to guidelines for conducting research in humans and animals. If the editors become aware of research misconduct after a manuscript has been published, the editors will contact the authors and notify the readers.
V. Submission Process
Wound Management & Prevention will work with one author (designated the “corresponding author”) who will be responsible for all correspondence regarding submission, review, revision, and acceptance. It is the responsibility of the corresponding author to ensure all deadlines are met and all documents are distributed to additional authors and returned promptly. It is also the author’s responsibility to keep the Editors abreast of his/her reliable contact information.
A. Sending the Manuscript/Materials
All manuscript materials are to be submitted using the online Editorial Manager system at: www.edmgr.com/OWM/default.aspx (we will continue to use our old log in). Authors should select the Author option and follow the online instructions found at this website for uploading the manuscript and all related material.
Questions regarding the submission process can be directed to the Associate Editor, Wound Management & Prevention, 70 E. Swedesford Road, Suite 100, Malvern, PA 19355; 610-560-0500, extension 4135; or emailed to: firstname.lastname@example.org.
If for any reason the author is unable to submit manuscript materials through the online system, said materials may be submitted to the Editor via email (email@example.com) as Word documents. Tables should appear at the end of the manuscript. Photographs (high-resolution) and figures should not be embedded in the Word document; they should be provided as separate files. All submissions must include 1) a cover letter, 2) signed financial disclosure and copyright documents and previous publication statement (see III), and 3) a title page. All photos must comply with current HIPAA regulations protecting patient identity.
Persons without access to the Internet should contact the Editor directly (see contact information to follow) for instructions on hard-copy submission. All aforementioned materials would need to be copied to a CD-ROM and mailed to:
Barbara C. Zeiger, Editor
Wound Management & Prevention
70 E. Swedesford Road, Suite 100
Malvern, PA 19355
(800) 237-7285, ext. 4244 or (610) 560-0500, ext. 4244
(610) 560-0502 (fax)
VI. The Manuscript Review and Publication Process
All submitted manuscripts go through at least 2 review cycles. During the first level of review, the manuscript may be forwarded for peer review or the author may receive a letter indicating the manuscript is not accepted for publication or that revisions are needed. The second level (peer) review process involves a minimum of three Editorial Board members from the discipline(s) relevant to the manuscript.
The manuscript peer-review process is double-blind; the identity of the author(s) is not revealed to the reviewers. Manuscripts are reviewed for accuracy, completeness, concordance with above-mentioned requirements, their contribution to new knowledge, relevance to the focus of the journal, timeliness, and originality. This part of the review process takes approximately 8 weeks. Author(s) will receive a letter indicating whether the manuscript has been accepted for publication, as well as all reviewer comments and revision requests.
If the manuscript is accepted for publication, authors will be asked to return the revised manuscript after approximately 3 to 4 weeks. Manuscripts will not be scheduled for publication until the revised manuscript has been received and re-reviewed.
Just before publication, manuscripts undergo one last review/revision to address remaining queries and provide final clarification. This helps the Editors provide the cleanest possible copy to create the finished article.
Two (2) to 4 weeks before publication, galley proofs will be provided to the author, who will need to respect a relatively quick turn-around time (2 to 3 business days) to approve the final manuscript and/or make minor changes.
1. American Medical Association. Manual of Style: A Guide for Authors and Editors, 10th ed. Oxford, UK: Oxford University Press;2007.
2. American Psychological Association. Publication Manual of the American Psychological Association, 6th ed. Washington, DC: American Psychological Association;2010.
3. International Committee of Medical Journal Editors. Available at: www.icmje.org/. Accessed July 6, 2017.
4. Editorial Policy Committee (2005-2006), Council of Science Editors. SE’s White paper on promoting integrity in scientific journal publications. Available at: www.CouncilScienceEditors.org. Accessed July 6, 2017.